Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
暂无分享,去创建一个
H. Ditzel | Å. Borg | I. Hedenfalk | A. Ehinger | K. Harbst | J. Staaf | Srinivas Veerla | A. Bosch | S. Borgquist | G. Honeth | Anna Ebbesson | A. Pérez-Fidalgo | Kamila K. Kaminska | Lukas Beumers | N. Akrap | S. Ehmsen | Carla L. Alves